MicroRNAs in cardiovascular disease: From pathogenesis to prevention and treatment

Daniel Quiat, Eric N. Olson

Research output: Contribution to journalArticle

166 Citations (Scopus)

Abstract

The management of cardiovascular risk through lifestyle modification and pharmacotherapy is paramount to the prevention of cardiovascular disease. Epidemiological studies have identified obesity, dyslipidemia, diabetes, and hypertension as interrelated factors that negatively affect cardiovascular health. Recently, genetic and pharmacological evidence in model systems has implicated microRNAs as dynamic modifiers of disease pathogenesis. An expanded understanding of the function of microRNAs in gene regulatory networks associated with cardiovascular risk will enable identification of novel genetic mechanisms of disease and inform the development of innovative therapeutic strategies.

Original languageEnglish (US)
Pages (from-to)11-18
Number of pages8
JournalJournal of Clinical Investigation
Volume123
Issue number1
DOIs
StatePublished - Jan 2 2013

Fingerprint

MicroRNAs
Cardiovascular Diseases
Inborn Genetic Diseases
Gene Regulatory Networks
Risk Management
Dyslipidemias
Life Style
Epidemiologic Studies
Obesity
Pharmacology
Hypertension
Drug Therapy
Health
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

MicroRNAs in cardiovascular disease : From pathogenesis to prevention and treatment. / Quiat, Daniel; Olson, Eric N.

In: Journal of Clinical Investigation, Vol. 123, No. 1, 02.01.2013, p. 11-18.

Research output: Contribution to journalArticle

@article{5af2daa462d14ce3bc623c080c54370d,
title = "MicroRNAs in cardiovascular disease: From pathogenesis to prevention and treatment",
abstract = "The management of cardiovascular risk through lifestyle modification and pharmacotherapy is paramount to the prevention of cardiovascular disease. Epidemiological studies have identified obesity, dyslipidemia, diabetes, and hypertension as interrelated factors that negatively affect cardiovascular health. Recently, genetic and pharmacological evidence in model systems has implicated microRNAs as dynamic modifiers of disease pathogenesis. An expanded understanding of the function of microRNAs in gene regulatory networks associated with cardiovascular risk will enable identification of novel genetic mechanisms of disease and inform the development of innovative therapeutic strategies.",
author = "Daniel Quiat and Olson, {Eric N.}",
year = "2013",
month = "1",
day = "2",
doi = "10.1172/JCI62876",
language = "English (US)",
volume = "123",
pages = "11--18",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "1",

}

TY - JOUR

T1 - MicroRNAs in cardiovascular disease

T2 - From pathogenesis to prevention and treatment

AU - Quiat, Daniel

AU - Olson, Eric N.

PY - 2013/1/2

Y1 - 2013/1/2

N2 - The management of cardiovascular risk through lifestyle modification and pharmacotherapy is paramount to the prevention of cardiovascular disease. Epidemiological studies have identified obesity, dyslipidemia, diabetes, and hypertension as interrelated factors that negatively affect cardiovascular health. Recently, genetic and pharmacological evidence in model systems has implicated microRNAs as dynamic modifiers of disease pathogenesis. An expanded understanding of the function of microRNAs in gene regulatory networks associated with cardiovascular risk will enable identification of novel genetic mechanisms of disease and inform the development of innovative therapeutic strategies.

AB - The management of cardiovascular risk through lifestyle modification and pharmacotherapy is paramount to the prevention of cardiovascular disease. Epidemiological studies have identified obesity, dyslipidemia, diabetes, and hypertension as interrelated factors that negatively affect cardiovascular health. Recently, genetic and pharmacological evidence in model systems has implicated microRNAs as dynamic modifiers of disease pathogenesis. An expanded understanding of the function of microRNAs in gene regulatory networks associated with cardiovascular risk will enable identification of novel genetic mechanisms of disease and inform the development of innovative therapeutic strategies.

UR - http://www.scopus.com/inward/record.url?scp=84873817376&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873817376&partnerID=8YFLogxK

U2 - 10.1172/JCI62876

DO - 10.1172/JCI62876

M3 - Article

C2 - 23281405

AN - SCOPUS:84873817376

VL - 123

SP - 11

EP - 18

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 1

ER -